The IASLC Lung Cancer News (ILCN) is the IASLC's official news medium for thoracic oncology specialists around the globe. ILCN provides its international audience with timely and relevant lung cancer news on topics across specialties and interests, such as novel clinical trial design and statistics, overcoming barriers to NGS testing, tobacco control and smoking/vaping cessation, patient-driven research, patient communication and care delivery during COVID, and more. Only the IASLC—the only international association dedicated to the study of lung cancer—can bring you multidisciplinary nuanced perspectives on daily clinical conundrums and the latest novel research by the true experts in the field.
Featured
ILCN Digital Edition
December 2021 Digital Edition!
What's Inside:
- Getting Involved in Lung Cancer Advocacy at the Government Level in the United States
- Novel RET Inhibitors Promising in Chinese Patients with RET-fusion Positive NSCLC
- Determining Adjuvant Therapy Through Recurrence Prediction: New Investigations
- A Global First: New Zealand to Phase Out Legal Tobacco Sales Within 4 Years
- Psychosocial Needs Remain Largely Unmet for Patients with Lung Cancer, Caregivers
- The Phase II KEYNOTE-799 Trial in Perspective
Evolving Standards of Care
Screening and Early Detection
Industry News & Regulatory Approvals
Patient Advocacy
Names and News
Podcasts
Meeting News
Studies Question Further Modification of pTNM Staging as 9th Edition Deadline Approaches
Rare NUT Carcinoma Gaining Recognition in Lung Cancer Community
Press Releases
